Pfizer Admits They Don’t Know If Vax Will Give Kids Myocarditis
The Pro Trump News homepage has 60 new headlines every 24 hours - click here to see it.
The push to vaccinate kids continues.
Pfizer has now admitted that they don’t have enough data to know if their vaccine would give kids myocarditis.
They said they will do studies over the next five years to find out.
Per @pfizer – we don’t know the risks or long term sequelae of vaccine-induced myocarditis in kids but we’ll have the answer for you in (checks briefing document) 5 years: https://t.co/gABG7youQx pic.twitter.com/foSyxkcifP
— Ramin Farzaneh-Far MD (@rfsquared) October 22, 2021
They are pushing it on kids anyway.
Pfizer says its COVID-19 vaccine more than 90% effective in kidshttps://t.co/3zlFeBfInA
— Fox News (@FoxNews) October 22, 2021
Kid-size doses of the Pfizer BioNTech COVID-19 vaccine appear to be safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday.
This news comes as the nation considers opening vaccinations to that age group, with shots beginning in early November if regulators give the green light.
The U.S. Food and Drug Administration (FDA) was expected to post its own independent review of the company’s safety and effectiveness data later in the day.
There has been a problem with people under 30 and getting myocarditis or pericarditis.
Federal health officials have verified 226 cases of myocarditis or pericarditis in people ages 30 and younger who have received an mRNA COVID-19 vaccine and are investigating about 250 more reports.
While rare, the rates for ages 16-24 following a second dose are above what is expected, prompting an emergency meeting of the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) next week.
“At that time, we’ll update the data, further evaluate myocarditis following mRNA vaccination and assess benefit/risk analysis,” said Tom Shimabukuro, M.D., M.P.H., M.B.A., deputy director of the Centers for Disease Control and Prevention’s (CDC’s) Immunization Safety Office.
Dr. Shimabukuro made a presentation Thursday to the Food and Drug Administration’s (FDA’s) vaccine advisory group where he said across all ages, 789 cases of myocarditis/pericarditis have been reported after the Pfizer/BioNTech and Moderna vaccines, most commonly after the second dose. Cases predominantly have been seen in males, and the median age for a case of myocarditis following dose two is 24.
Advertisement
